| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |